Healthcare Sales & Marketing Network News: Karolinska Development

Searching News Database: Karolinska Development

HSMN NewsFeed - 16 Apr 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 25 Mar 2019
Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Feb 2019
Aprea Therapeutics Adds New Investor to Series C Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 13 Jul 2018
Modus Therapeutics Completes a SEK 140 Million Financing led by HealthCap
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Mar 2016
Karolinska Development's Portfolio Company Aprea Raises SEK 437 Million
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 27 Apr 2010
Axelar's Board Strengthened
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Jan 2009
Novel Product for Post Surgical Scar Formation Entering Clinical Development
Biopharmaceuticals Surgery

Return to NewsFeed

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!